Discordant HIV tests ten days after a needle-stick
A 26-year-old staff nurse sustains a hollow-bore needle-stick while recapping a cannula after taking blood from a patient known to be HIV-positive and not on antiretroviral therapy; the patient's last viral load was 100,000 copies/mL. She washes the site, reports within 30 minutes and starts post-exposure prophylaxis 4 hours after the injury. On day 10 she is tested: HIV antibody ELISA is negative, but an HIV-1 RNA PCR reports 800 copies/mL. One colleague tells her the negative ELISA means she is 'fine'; another says a viral load of 800 means she is 'highly infectious and should stay away from her family'. She is due to donate blood at a college camp next week and asks whether she may.
1. Reconcile the two results. What does each test detect, and what is the appropriate diagnostic plan from here?
Read the worked answer
The two tests look at different markers with different kinetics, so they do not contradict each other at day 10. The ELISA detects anti-HIV antibodies, which appear about 3-6 weeks after exposure and can take up to 3 months; a negative result at day 10 is exactly what is expected and carries no reassurance. The RNA PCR detects viral nucleic acid, detectable from roughly day 10-14, which is why it can be positive while serology is still negative.
So she is neither 'fine' nor proven infected. A single low-level RNA result can be a false positive, especially near the limit of detection. The plan is to confirm with a second assay targeting a different genomic region (for example integrase) and to repeat a fourth-generation combined antigen/antibody test at 6 weeks, 3 months and 6 months. Post-exposure prophylaxis can blunt and delay seroconversion, so the 3- and 6-month samples matter and must not be dropped if the earlier ones are negative.
All decisions on continuing or changing prophylaxis belong to the treating physician; the biology student's task is to interpret the timelines correctly.
2. Interpret the value of 800 copies/mL and the significance of starting prophylaxis at 4 hours. How does it compare with the source patient's 100,000 copies/mL in terms of transmission risk?
Read the worked answer
Eight hundred copies per millilitre is a low viral load, but at day 10 it is an early point on a curve that rises exponentially for weeks; a low value now predicts nothing about week 4. The source's 100,000 copies/mL is high, and transmission risk scales with inoculum, so a high source load, a hollow-bore needle, a deep injury and visible blood on the device all raise the probability of infection.
Prophylaxis at 4 hours is within the 72-hour window, but the benefit is greatest the sooner it starts - ideally within 2 hours - so 4 hours is acceptable rather than ideal, and completing the full 28-day course matters more than the exact hour. Correctly taken, prophylaxis reduces the risk of infection by roughly 80% or more, which is why it is offered at all.
Neither colleague's conclusion is supported. 800 copies does not mean highly infectious, and casual family contact - sharing food, hugging, using the same toilet - transmits nothing. Nor does it mean she is safe. The value must be repeated, not interpreted in isolation.
3. Advise her on the blood donation and on precautions at home. How would your interpretation change if the source patient had had an undetectable viral load on long-term antiretroviral therapy?
Read the worked answer
She must not donate blood. Her infection status is unresolved, and the antibody window period is precisely the reason a recently exposed person can test negative and still transmit; blood banks rely on donor honesty about exposures at least as much as on screening. Donating now, or in the next 6 months, would put recipients at risk and is against donor criteria.
At home she needs no isolation. The precautions that have a biological basis are avoiding shared razors, toothbrushes or nail clippers, covering open wounds, and using condoms until her status is clarified. She should keep all follow-up appointments, report fever, rash, sore throat or lymphadenopathy, and be told that a negative test at 3 months with a fourth-generation assay is strongly but not absolutely reassuring.
If the source had had a confirmed undetectable viral load for more than 6 months on stable therapy, the inoculum and transmission risk would be very much lower, and some guidelines would not recommend prophylaxis after such an exposure. Because the exposure was high-risk percutaneous, however, the decision would still be made by the treating physician, with the source's adherence history checked - an undetectable result from an unreliable regimen is not reassuring.